The Female Health Company (M) Sdn Bhd ("FHCM"), is based in Cheras Jaya, Selangor. Head quartered in Chicago, IL, FHCM manufactures, markets and sells the female initiated Barrier Contraceptive. It is the only such product approved by both the U.S. Food and Drug Administration (FDA) and the World Health Organisation (WHO) for public sector programs. The Female Health Company US is publically traded on NASDAQ. The product is currently sold or available through various channels in 108 countries. It is commercially marketed directly to consumers in 10 countries by various country specific partners, including in the United States, the United Kingdom, Canada and France.
The Female Health Company (M) Sdn Bhd ("FHCM"), is based in Cheras Jaya, Selangor. Head quartered in Chicago, IL, FHCM manufactures, markets and sells the female initiated Barrier Contraceptive. It is the only such product approved by both the U.S. Food and Drug Administration (FDA) and the World Health Organisation (WHO) for public sector programs. The Female Health Company US is publically traded on NASDAQ. The product is currently sold or available through various channels in 108 countries. It is commercially marketed directly to consumers in 10 countries by various country specific partners, including in the United States, the United Kingdom, Canada and France.
The Female Health Company (M) Sdn Bhd ("FHCM"), is based in Cheras Jaya, Selangor. Head quartered in Chicago, IL, FHCM manufactures, markets and sells the female initiated Barrier Contraceptive. It is the only such product approved by both the U.S. Food and Drug Administration (FDA) and the World Health Organisation (WHO) for public sector programs. The Female Health Company US is publically traded on NASDAQ. The product is currently sold or available through various channels in 108 countries. It is commercially marketed directly to consumers in 10 countries by various country specific partners, including in the United States, the United Kingdom, Canada and France.